Latest News
- November 18, 2025ANDA application for Bimatoprost ophthalmic solution received Marketing Authorization from the USFDA!
- November 12, 2025ANDA application for Risperidone extended-release injectable suspension has received Marketing Authorization from the USFDA!
- October 30, 2025Accelerating Clinical Research!
- September 12, 2025Join CBCC at CPHI Frankfurt 2025
- August 08, 2025International Publication of Phase II clinical Trial
September 14, 2022
Attending AAO 2022 Annual Meeting at Chicago
CBCC Global Research will be attending AAO 2022 Annual Meeting during 30 Sept. to 3 Oct. 2022, at McCormick Place, Chicago.
For more information about this conference, please visit: https://lnkd.in/dCK33m7
For business appointments please email us at bd@cbcc.global
Submit RFP to CBCC Global Research for your clinical program(s):
https://lnkd.in/dGEP2wy3